GO
Loading...

Sanofi CEO on Profit Pipeline

Thursday, 12 Apr 2012 | 4:35 PM ET

Sanofi CEO Christopher Viehbacher discusses his company's $20 billion acquisition of Genzyme and other opportunities he sees in the pharmaceutical market.